Mario F Mendez1,2,3, Pongsatorn Paholpak1,2,3, Andrew Lin1,2,3, Jeannie Y Zhang2, Edmond Teng1,2,3. 1. Department of Neurology, University of California Los Angeles (UCLA), Los Angeles, CA, USA. 2. David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. 3. Department of Neurology, Neurobehavior Unit, V.A. Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Abstract
BACKGROUND: Traumatic brain injury (TBI) is the most established environmental risk factor for Alzheimer's disease (AD), but it is unclear if TBI is specifically associated with early-onset AD (EOAD). OBJECTIVE: To evaluate the relationship between TBI and EOAD (<65 years). METHODS: We identified 1,449 EOAD, 4,337 late-onset AD (LOAD), and corresponding EOAD-matched and LOAD-matched normal controls (NC) in the National Alzheimer's Coordinating Center Uniform (NACC) database and compared the prevalence of any history of TBI as well as measures of cognition, function, behavior, and neuropathology. For validation, we determined TBI prevalence among 115 well-characterized clinic patients with EOAD. RESULTS: Part A: The prevalence of any TBI in the NACC-database EOAD participants (13.3%) was comparable to that observed in the clinic EOAD patients (13.9%) but significantly higher than in the NACC-database LOAD participants (7.7% ; p < 0.0001) and trended to higher compared to EOAD-matched NC (11.1% ; logistic regression p = 0.053). Part B: When we compared EOAD patients with documented non-acute and non-residually impairing TBI to EOAD without a documented history of prior TBI, those with TBI had significantly more disinhibition. Part C: Autopsies did not reveal differences in AD neuropathology based on a history of TBI. CONCLUSIONS: These findings suggest, but do not establish, that TBI is a specific risk factor for EOAD and may lead to disinhibition, a feature that often results from the frontal effects of head injury. This study recommends further research on the effects of TBI in EOAD in larger numbers of participants.
BACKGROUND:Traumatic brain injury (TBI) is the most established environmental risk factor for Alzheimer's disease (AD), but it is unclear if TBI is specifically associated with early-onset AD (EOAD). OBJECTIVE: To evaluate the relationship between TBI and EOAD (<65 years). METHODS: We identified 1,449 EOAD, 4,337 late-onset AD (LOAD), and corresponding EOAD-matched and LOAD-matched normal controls (NC) in the National Alzheimer's Coordinating Center Uniform (NACC) database and compared the prevalence of any history of TBI as well as measures of cognition, function, behavior, and neuropathology. For validation, we determined TBI prevalence among 115 well-characterized clinic patients with EOAD. RESULTS: Part A: The prevalence of any TBI in the NACC-database EOAD participants (13.3%) was comparable to that observed in the clinic EOAD patients (13.9%) but significantly higher than in the NACC-database LOAD participants (7.7% ; p < 0.0001) and trended to higher compared to EOAD-matched NC (11.1% ; logistic regression p = 0.053). Part B: When we compared EOAD patients with documented non-acute and non-residually impairing TBI to EOAD without a documented history of prior TBI, those with TBI had significantly more disinhibition. Part C: Autopsies did not reveal differences in AD neuropathology based on a history of TBI. CONCLUSIONS: These findings suggest, but do not establish, that TBI is a specific risk factor for EOAD and may lead to disinhibition, a feature that often results from the frontal effects of head injury. This study recommends further research on the effects of TBI in EOAD in larger numbers of participants.
Authors: B L Plassman; R J Havlik; D C Steffens; M J Helms; T N Newman; D Drosdick; C Phillips; B A Gau; K A Welsh-Bohmer; J R Burke; J M Guralnik; J C Breitner Journal: Neurology Date: 2000-10-24 Impact factor: 9.910
Authors: Robert A Stern; Daniel H Daneshvar; Christine M Baugh; Daniel R Seichepine; Philip H Montenigro; David O Riley; Nathan G Fritts; Julie M Stamm; Clifford A Robbins; Lisa McHale; Irene Simkin; Thor D Stein; Victor E Alvarez; Lee E Goldstein; Andrew E Budson; Neil W Kowall; Christopher J Nowinski; Robert C Cantu; Ann C McKee Journal: Neurology Date: 2013-08-21 Impact factor: 9.910
Authors: E Julia Chosy; Noele Gross; Marnie Meyer; Catherine Y Liu; Steven D Edland; Lenore J Launer; Lon R White Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: John Darrell Van Horn; Andrei Irimia; Carinna M Torgerson; Avnish Bhattrai; Zachary Jacokes; Paul M Vespa Journal: J Neurosci Res Date: 2017-05-20 Impact factor: 4.164
Authors: Raquel C Gardner; Ernesto Rivera; Megan O'Grady; Colin Doherty; Kristine Yaffe; John D Corrigan; Jennifer Bogner; Joel Kramer; Fiona Wilson Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Kimbra Kenney; Diego Iacono; Brian L Edlow; Douglas I Katz; Ramon Diaz-Arrastia; Kristen Dams-O'Connor; Daniel H Daneshvar; Allison Stevens; Allison L Moreau; Lee S Tirrell; Ani Varjabedian; Anastasia Yendiki; Andre van der Kouwe; Azma Mareyam; Jennifer A McNab; Wayne A Gordon; Bruce Fischl; Ann C McKee; Daniel P Perl Journal: J Neuropathol Exp Neurol Date: 2018-01-01 Impact factor: 3.685
Authors: Michael J C Bray; Lisa N Richey; Barry R Bryant; Akshay Krieg; Sahar Jahed; William Tobolowsky; Christian LoBue; Matthew E Peters Journal: Alzheimers Dement Date: 2021-01-19 Impact factor: 21.566